Skip to main content

Rapid cancer data and reporting

During the coronavirus (COVID-19) pandemic the National Disease Registration Service (NDRS) worked to provide near real-time data for England to support clinical and policy decision making.  

Introduction

The coronavirus (COVID-19) pandemic brought the importance of health data to the fore. During the pandemic NDRS developed and published new, near real-time data sets to support clinical and policy decision making with the restoration of normal clinical care provision to patients.


Interactive data tools

These data sets and dashboards were developed and produced during the coronavirus pandemic to support the public health response.  However, as they are still regularly used to support clinical and political decision making, they are continually updated beyond the pandemic.

The NDRS interactive tools can be accessed in two ways:

  1. Visit the publicly accessible CancerData platform or

  2. For NHS users, visit the CancerStats2 platform if you have a secure HSCN connection (this link opens in a new window)

The Rapid Cancer Registration Dataset (RCRD)

The RCRD is aimed at supporting near-real time analysis of cancer data in relation to coronavirus. This dataset is used for the Rapid Cancer Registration and Treatment dashboard, which is available publicly on CancerData, or with more details for NHS users on CancerStats2. The data is available to request through the Data Access Request Service (DARS).

Visit the RCRD page to find out more about this data

Radiotherapy Data Set (RTDS) dashboard

The RTDS dashboard aims to provide a suite of radiotherapy metrics relevant to coronavirus, to support decision making on cancer services.

Visit the RTDS page to find out more about this data.

Systematic Anti-Cancer Therapy (SACT) dashboard

The SACT dashboard aims to provide a suite of chemotherapy metrics relevant to coronavirus, to support decision making on cancer services.

Visit the SACT page to find out more about this data. 

Coronavirus cancer equality data packs

The coronavirus cancer equity data packs provide national and regional activity data on both the number of urgent suspected cancer (Two-Week Wait) referrals and first definitive treatments for cancer. The data is broken down by tumour type and patient factors: deprivation, age, sex and ethnicity. The equity packs are produced by the Cancer Alliance Data, Evidence and Analysis Service (CADEAS) and the National Cancer Registration and Analysis Service (NCRAS).

Visit the CADEAS page to find out more about this work. 


Feedback and support

We are here to help and value feedback and suggestions for how we can improve rapid cancer data and reporting. 

If you need any help or support or queries regarding reporting or access to this data, please contact the team at [email protected].

Last edited: 6 September 2023 4:50 pm